Yahoo Web Search

Search results

    • Q1 2024 Voyager Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 1 day ago

      This includes tofersen, the first genetically targeted therapy to be FDA-approved for SOD1-ALS and the first treatment to receive accelerated approval based on plasma neurofilament ...